newsfilter
← Latest News
GlobeNewswire·

Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022

Reporting its financial results and continued progress across short-acting psychedelics portfolio Executive team and IP position strengthened LONDON, June 09, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF) (the "Company" or "